Massive Rise, page-28

As far as I can tell, CPH is the only cannabis stock with the deals in place to take advantage of legislative change for medical cannabis laws immediately (aside from Cann group yet to list). Is that right?

They have a deal with Health House, Health House has been granted a import license for medical cannabis and have the pharmacy to dispense it.

And, little ol' Australian medical cannabis market is really only a sideline compared to their other product developments and deals, imo.

Whether the gap is closed or not there should be a lot more value here.